Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.

Clinical chemistry and laboratory medicine - 1 Feb 2016

Kontos Christos K, Adamopoulos Panagiotis G, Papageorgiou Sotirios G, Pappa Vassiliki, Scorilas Andreas

Abstract excerpt

BACKGROUND: Tissue kallikrein and kallikrein-related peptidases (KLKs) compose a family of serine endopeptidases with much clinical interest in oncology, as their potential as diagnostic and/or prognostic molecular biomarkers in several human malignancies has already been evidenced. However, none of the members of this family has ever been studied in hematological malignancies. Based on our preliminary results...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to Complementarity Determining Regions

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Rearrangement

Share to Immunophenotyping

Share to Kallikreins

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Leukocytes, Mononuclear

Share to ROC Curve

Source

Identifiers

PMID: 26351937
DOI: 10.1515/cclm-2015-0456

Genes

KLK14

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.PMID 26351937Read ↗

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosisSemantic proximity Read ↗

MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.Semantic proximity Read ↗

Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 – KLK9), using Next-generation sequencingSemantic proximity Read ↗

Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancerSemantic proximity Read ↗

Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancerSemantic proximity Read ↗

Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkersSemantic proximity Read ↗

Kallikrein-related peptidases (KLKs) and the hallmarks of cancerSemantic proximity Read ↗

Kallikrein-related peptidase 13 (KLK13) gene expressional status contributes significantly in the prognosis of primary gastric carcinomas.Semantic proximity Read ↗

Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignanciesSemantic proximity Read ↗

Prognostic relevance of angiopoietin-2, fibroblast growth factor-2 and endoglin mRNA expressions in chronic lymphocytic leukemia.Semantic proximity Read ↗

Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impactSemantic proximity Read ↗

IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.